FAM90A26: A Promising Drug Target / Biomarker (G100287045)

Target Name: FAM90A26

NCBI ID: G100287045

FAM90A26

FAM90A26: A Promising Drug Target / Biomarker

FAM90A26 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of inflammation and cellular signaling. As a drug target or biomarker, FAM90A26 is of interest to researchers because it can be targeted with small molecules or antibodies to modulate its activity and potentially treat a variety of diseases.

FAM90A26 and its function:
FAM90A26 is a member of the FAM (FAMILY member 90) gene family, which is characterized by the presence of a specific domain called the FAM90A domain. This domain is responsible for the protein's unique structure and function. FAM90A26 is expressed in a variety of tissues and is involved in the regulation of cellular signaling pathways, including inflammation and cell-cell adhesion.

One of the most significant functions of FAM90A26 is its role in the regulation of inflammation. In response to an infection or injury, FAM90A26 is involved in the recruitment of immune cells to the site of inflammation. This is accomplished through its interaction with the immune cell receptor PD-L1, which is expressed in the immune cells themselves. By interacting with PD-L1, FAM90A26 helps to stimulate the immune response and promote the recruitment of immune cells to the site of inflammation.

Another function of FAM90A26 is its role in cell-cell adhesion. FAM90A26 is involved in the regulation of cell-cell adhesion by interacting with the cell adhesion molecule E-cadherin. This interaction helps to regulate the movement of cells along the body's surface and ensure that they stick together in order to maintain tissue structure and function.

FAM90A26 and its potential as a drug target:
FAM90A26 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular signaling pathways. As a drug target or biomarker, FAM90A26 is of interest to researchers because it can be targeted with small molecules or antibodies to modulate its activity and potentially treat a variety of diseases.

One potential way to target FAM90A26 is with small molecules that can modulate its activity in the regulation of inflammation and cell-cell adhesion. For example, researchers could synthesize compounds that interact with FAM90A26 and modulate its activity in these processes. These compounds could then be tested for their ability to treat a variety of diseases, such as cancer, autoimmune diseases, and inflammatory disorders.

Another potential way to target FAM90A26 is with antibodies that recognize and bind to it. These antibodies could then be used to treat diseases that are caused by the overproduction or underproduction of FAM90A26. For example, researchers could develop antibodies that recognize FAM90A26 and target it to the immune system, where they could be eliminated by the body's immune cells.

Conclusion:
FAM90A26 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular signaling pathways, including inflammation and cell-cell adhesion. As a drug target or biomarker, FAM90A26 is of interest to researchers because it can be targeted with small molecules or antibodies to modulate its activity and potentially treat a variety of diseases. Further research is needed to fully understand the functions of FAM90A26 and its potential as a drug target.

Protein Name: Family With Sequence Similarity 90 Member A26

The "FAM90A26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets